Cargando…

Pituitary adenomas: a review

Pituitary adenomas, as the majority of pituitary neoplasms, are typically benign, slow-growing tumors that arise from cells in the pituitary gland. Those are classified based on secretory products. The functioning (endocrine-active) tumors include almost 70% of pituitary tumors which produce 1 or 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharif-Alhoseini, Mahdi, Rahimi-Movaghar, Vafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kermanshah University of Medical Sciences 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571582/
_version_ 1782259184342925312
author Sharif-Alhoseini, Mahdi
Rahimi-Movaghar, Vafa
author_facet Sharif-Alhoseini, Mahdi
Rahimi-Movaghar, Vafa
author_sort Sharif-Alhoseini, Mahdi
collection PubMed
description Pituitary adenomas, as the majority of pituitary neoplasms, are typically benign, slow-growing tumors that arise from cells in the pituitary gland. Those are classified based on secretory products. The functioning (endocrine-active) tumors include almost 70% of pituitary tumors which produce 1 or 2 hormones that are measurable in the serum and cause definite clinical syndromes, that are classified based on their secretory product(s). But non-functioning adenomas are endocrine-inactive tumors. The purpose of this study is to review all types of functioning pituitary adenoma (prolactin, ACTH, GH, TSH, LH and FSH secreting) and non-secreting ones from studies indexed in electronic databases. We describe the symptoms, epidemiology, diagnosis, management, outcome and complications of them separately. Because of physiologic effects of excess hormones, the functioning tumors present earlier than non-functioning adenomas. Therefore patients usually present with symptoms related to a specific hormone imbalance. On the other hand, the mass effect from large pituitary adenomas (often due to non-secreting tumors) may lead to the pressure symptoms, such as headaches, visual field defects (typically loss of peripheral vision first), cranial nerve deficits, hypopituitarism (compression of the normal pituitary gland), pituitary apoplexy (sudden bleeding or outgrowing blood supply), or stalk effect. Apart from prolactinomas, primary treatment for the pituitary adenomas is usually transsphenoidal surgery, and adjunctive treatment may include supervoltage radiation, and occasionally, pharmacologic agents. The most of prolactinomas can be effectively treated with dopaminergic drugs as a primary therapy. Transsphenoidal surgery is an alternative for patients who are intolerant of or resistant to dopamine agonists or when hyperprolactinemia is caused by non-prolactin-secreting tumors compressing the pituitary stalk. KEYWORDS: Pituitary neoplasm, Prolactinoma, ACTH-Secreting pituitary adenoma, GH-Secreting pituitary adenoma
format Online
Article
Text
id pubmed-3571582
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Kermanshah University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-35715822013-03-19 Pituitary adenomas: a review Sharif-Alhoseini, Mahdi Rahimi-Movaghar, Vafa J Inj Violence Res Poster Presentation Pituitary adenomas, as the majority of pituitary neoplasms, are typically benign, slow-growing tumors that arise from cells in the pituitary gland. Those are classified based on secretory products. The functioning (endocrine-active) tumors include almost 70% of pituitary tumors which produce 1 or 2 hormones that are measurable in the serum and cause definite clinical syndromes, that are classified based on their secretory product(s). But non-functioning adenomas are endocrine-inactive tumors. The purpose of this study is to review all types of functioning pituitary adenoma (prolactin, ACTH, GH, TSH, LH and FSH secreting) and non-secreting ones from studies indexed in electronic databases. We describe the symptoms, epidemiology, diagnosis, management, outcome and complications of them separately. Because of physiologic effects of excess hormones, the functioning tumors present earlier than non-functioning adenomas. Therefore patients usually present with symptoms related to a specific hormone imbalance. On the other hand, the mass effect from large pituitary adenomas (often due to non-secreting tumors) may lead to the pressure symptoms, such as headaches, visual field defects (typically loss of peripheral vision first), cranial nerve deficits, hypopituitarism (compression of the normal pituitary gland), pituitary apoplexy (sudden bleeding or outgrowing blood supply), or stalk effect. Apart from prolactinomas, primary treatment for the pituitary adenomas is usually transsphenoidal surgery, and adjunctive treatment may include supervoltage radiation, and occasionally, pharmacologic agents. The most of prolactinomas can be effectively treated with dopaminergic drugs as a primary therapy. Transsphenoidal surgery is an alternative for patients who are intolerant of or resistant to dopamine agonists or when hyperprolactinemia is caused by non-prolactin-secreting tumors compressing the pituitary stalk. KEYWORDS: Pituitary neoplasm, Prolactinoma, ACTH-Secreting pituitary adenoma, GH-Secreting pituitary adenoma Kermanshah University of Medical Sciences 2012-11 /pmc/articles/PMC3571582/ Text en Copyright © 2012, KUMS http://creativecommons.org/licenses/by/3/ This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Sharif-Alhoseini, Mahdi
Rahimi-Movaghar, Vafa
Pituitary adenomas: a review
title Pituitary adenomas: a review
title_full Pituitary adenomas: a review
title_fullStr Pituitary adenomas: a review
title_full_unstemmed Pituitary adenomas: a review
title_short Pituitary adenomas: a review
title_sort pituitary adenomas: a review
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571582/
work_keys_str_mv AT sharifalhoseinimahdi pituitaryadenomasareview
AT rahimimovagharvafa pituitaryadenomasareview